PDCD1 and mesothelioma: While some trials have demonstrated efficacy of anti-PD-1 and anti-PD-L1 therapy in mesothelioma, which target programmed cell death protein 1 and programmed cell death 1 ligand 1, respectively, the representation of PeM cases in these studies has been very limited owing to their relative rarity.